AGÕæÈ˹ٷ½

STOCK TITAN

[SC14D9C] Y-mAbs Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SC14D9C
Rhea-AI Filing Summary

8x8, Inc. (EGHT) â€� Form 4 filing: Director Todd R. Ford received 66,502 restricted stock units (RSUs) on 07/25/2025. The award has a $0 purchase price and will vest and settle in common shares on the earlier of 25 Jul 2026 or the next annual shareholder meeting, provided Ford remains in service. After this grant, Ford’s direct beneficial ownership increases to 250,609 shares.

No shares were sold, and no derivative securities were exercised or disposed of. Because the grant is part of routine board compensation, the cash impact to Ford and the company is minimal, but the filing does marginally increase insider equity alignment. The document contains no operational, earnings or guidance information.

8x8, Inc. (EGHT) � Deposito Form 4: Il direttore Todd R. Ford ha ricevuto 66.502 unità azionarie vincolate (RSU) il 25/07/2025. L'assegnazione ha un prezzo di acquisto pari a $0 e si maturerà e sarà regolata in azioni ordinarie entro la data più vicina tra il 25 luglio 2026 o la prossima assemblea annuale degli azionisti, a condizione che Ford rimanga in servizio. Dopo questa concessione, la posizione diretta di Ford aumenta a 250.609 azioni.

Non sono state vendute azioni né sono stati esercitati o ceduti strumenti derivati. Poiché la concessione fa parte della normale compensazione del consiglio, l'impatto finanziario per Ford e per la società è minimo, ma il deposito aumenta leggermente l'allineamento azionario degli insider. Il documento non contiene informazioni operative, sugli utili o sulle previsioni.

8x8, Inc. (EGHT) � Presentación Formulario 4: El director Todd R. Ford recibió 66,502 unidades restringidas de acciones (RSUs) el 25/07/2025. La concesión tiene un precio de compra de $0 y se consolidará y liquidará en acciones ordinarias en la fecha que ocurra primero entre el 25 de julio de 2026 o la próxima junta anual de accionistas, siempre que Ford continúe en servicio. Tras esta asignación, la propiedad directa beneficiaria de Ford aumenta a 250,609 acciones.

No se vendieron acciones ni se ejercieron o dispusieron valores derivados. Dado que la concesión es parte de la compensación rutinaria del consejo, el impacto en efectivo para Ford y la compañía es mínimo, aunque la presentación incrementa ligeramente el alineamiento accionarial de los insiders. El documento no contiene información operativa, de ganancias ni de previsiones.

8x8, Inc. (EGHT) â€� Form 4 제출: ì´ì‚¬ 토드 R. í¬ë“œëŠ� 2025ë…� 7ì›� 25ì¼ì— 66,502ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 받았습니ë‹�. ì� ë³´ìƒì€ 구매 ê°€ê²©ì´ $0ì´ë©°, í¬ë“œê°€ ê³„ì† ê·¼ë¬´í•˜ëŠ” ì¡°ê±´ í•˜ì— 2026ë…� 7ì›� 25ì� ë˜ëŠ” ë‹¤ìŒ ì—°ë¡€ 주주ì´íšŒ ì¤� 빠른 시ì¼ì—� 보통주로 ì·¨ë“ ë°� ì •ì‚°ë©ë‹ˆë‹�. ì´ë²ˆ ë¶€ì—� í›� í¬ë“œì� ì§ì ‘ 실질 소유 ì£¼ì‹ ìˆ˜ëŠ” 250,609주로 ì¦ê°€Çê©ë‹ˆë‹�.

주ì‹ì€ 매ë„ë˜ì§€ 않았으며, íŒŒìƒ ì¦ê¶Œë� 행사하거ë‚� 처분하지 않았습니ë‹�. ì� 부여는 ì´ì‚¬íš� 보수ì� ì¼í™˜ì´ë¯€ë¡� í¬ë“œì™€ 회사ì—� 대í•� 현금 ì˜í–¥ì€ 미미하지ë§�, 제출 서류ëŠ� ë‚´ë¶€ìž� ì£¼ì‹ ë³´ìœ  ì •ë ¬ì� 약간 ê°•í™”Çê©ë‹ˆë‹�. 문서ì—는 ìš´ì˜, ìˆ˜ìµ ë˜ëŠ” ê°€ì´ë˜ìŠ� ì •ë³´ê°€ í¬í•¨ë˜ì–´ 있지 않습니다.

8x8, Inc. (EGHT) � Dépôt du formulaire 4 : Le directeur Todd R. Ford a reçu 66 502 unités d’actions restreintes (RSU) le 25/07/2025. Cette attribution a un prix d’achat de 0 $ et sera acquise et réglée en actions ordinaires à la date la plus proche entre le 25 juillet 2026 ou la prochaine assemblée annuelle des actionnaires, à condition que Ford reste en fonction. Après cette attribution, la participation directe bénéficiaire de Ford augmente à 250 609 actions.

Aucune action n’a été vendue, et aucun produit dérivé n’a été exercé ou cédé. Étant donné que cette attribution fait partie de la rémunération habituelle du conseil d’administration, l’impact financier pour Ford et la société est minime, mais le dépôt augmente légèrement l’alignement des intérêts des initiés. Le document ne contient aucune information opérationnelle, sur les résultats ou les prévisions.

8x8, Inc. (EGHT) � Form 4 Einreichung: Direktor Todd R. Ford erhielt am 25.07.2025 66.502 Restricted Stock Units (RSUs). Die Zuteilung hat einen Kaufpreis von 0 $ und wird zum früheren Zeitpunkt zwischen dem 25. Juli 2026 oder der nächsten jährlichen Hauptversammlung in Stammaktien übertragen und abgewickelt, vorausgesetzt, Ford bleibt im Dienst. Nach dieser Zuteilung erhöht sich Fords direkter wirtschaftlicher Besitz auf 250.609 Aktien.

Es wurden keine Aktien verkauft, und es wurden keine Derivate ausgeübt oder veräußert. Da die Zuteilung Teil der routinemäßigen Vergütung des Vorstands ist, ist die finanzielle Auswirkung für Ford und das Unternehmen minimal, jedoch erhöht die Einreichung geringfügig die Insider-Aktienausrichtung. Das Dokument enthält keine operativen, Gewinn- oder Prognoseinformationen.

Positive
  • Increased insider alignment: Director’s holdings rise to 250,609 shares, modestly linking board incentives to shareholder value.
Negative
  • None.

Insights

TL;DR: Routine RSU grant; neutral cash impact, slightly higher insider ownership.

The 66.5k-share RSU grant is standard board compensation and involves no market purchase. It raises Ford’s stake to roughly 0.2% of outstanding shares (estimate based on ~125 M shares), a marginal but positive alignment signal. From a valuation or liquidity standpoint, the event is immaterial; dilution is de minimis and already factored into the equity compensation pool. Overall, the filing does not alter the investment thesis or near-term financial outlook.

TL;DR: Governance-consistent RSU award; no red flags.

The single-year vesting tied to continuous service is typical for non-employee directors and aligns with prevailing governance practices. No 10b5-1 plan was invoked, implying the grant occurred under the board’s regular compensation calendar. The transparent disclosure and absence of accelerated vesting clauses suggest sound governance. Investor impact is neutral; no signaling of strategic shifts or insider sentiment beyond routine alignment.

8x8, Inc. (EGHT) � Deposito Form 4: Il direttore Todd R. Ford ha ricevuto 66.502 unità azionarie vincolate (RSU) il 25/07/2025. L'assegnazione ha un prezzo di acquisto pari a $0 e si maturerà e sarà regolata in azioni ordinarie entro la data più vicina tra il 25 luglio 2026 o la prossima assemblea annuale degli azionisti, a condizione che Ford rimanga in servizio. Dopo questa concessione, la posizione diretta di Ford aumenta a 250.609 azioni.

Non sono state vendute azioni né sono stati esercitati o ceduti strumenti derivati. Poiché la concessione fa parte della normale compensazione del consiglio, l'impatto finanziario per Ford e per la società è minimo, ma il deposito aumenta leggermente l'allineamento azionario degli insider. Il documento non contiene informazioni operative, sugli utili o sulle previsioni.

8x8, Inc. (EGHT) � Presentación Formulario 4: El director Todd R. Ford recibió 66,502 unidades restringidas de acciones (RSUs) el 25/07/2025. La concesión tiene un precio de compra de $0 y se consolidará y liquidará en acciones ordinarias en la fecha que ocurra primero entre el 25 de julio de 2026 o la próxima junta anual de accionistas, siempre que Ford continúe en servicio. Tras esta asignación, la propiedad directa beneficiaria de Ford aumenta a 250,609 acciones.

No se vendieron acciones ni se ejercieron o dispusieron valores derivados. Dado que la concesión es parte de la compensación rutinaria del consejo, el impacto en efectivo para Ford y la compañía es mínimo, aunque la presentación incrementa ligeramente el alineamiento accionarial de los insiders. El documento no contiene información operativa, de ganancias ni de previsiones.

8x8, Inc. (EGHT) â€� Form 4 제출: ì´ì‚¬ 토드 R. í¬ë“œëŠ� 2025ë…� 7ì›� 25ì¼ì— 66,502ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 받았습니ë‹�. ì� ë³´ìƒì€ 구매 ê°€ê²©ì´ $0ì´ë©°, í¬ë“œê°€ ê³„ì† ê·¼ë¬´í•˜ëŠ” ì¡°ê±´ í•˜ì— 2026ë…� 7ì›� 25ì� ë˜ëŠ” ë‹¤ìŒ ì—°ë¡€ 주주ì´íšŒ ì¤� 빠른 시ì¼ì—� 보통주로 ì·¨ë“ ë°� ì •ì‚°ë©ë‹ˆë‹�. ì´ë²ˆ ë¶€ì—� í›� í¬ë“œì� ì§ì ‘ 실질 소유 ì£¼ì‹ ìˆ˜ëŠ” 250,609주로 ì¦ê°€Çê©ë‹ˆë‹�.

주ì‹ì€ 매ë„ë˜ì§€ 않았으며, íŒŒìƒ ì¦ê¶Œë� 행사하거ë‚� 처분하지 않았습니ë‹�. ì� 부여는 ì´ì‚¬íš� 보수ì� ì¼í™˜ì´ë¯€ë¡� í¬ë“œì™€ 회사ì—� 대í•� 현금 ì˜í–¥ì€ 미미하지ë§�, 제출 서류ëŠ� ë‚´ë¶€ìž� ì£¼ì‹ ë³´ìœ  ì •ë ¬ì� 약간 ê°•í™”Çê©ë‹ˆë‹�. 문서ì—는 ìš´ì˜, ìˆ˜ìµ ë˜ëŠ” ê°€ì´ë˜ìŠ� ì •ë³´ê°€ í¬í•¨ë˜ì–´ 있지 않습니다.

8x8, Inc. (EGHT) � Dépôt du formulaire 4 : Le directeur Todd R. Ford a reçu 66 502 unités d’actions restreintes (RSU) le 25/07/2025. Cette attribution a un prix d’achat de 0 $ et sera acquise et réglée en actions ordinaires à la date la plus proche entre le 25 juillet 2026 ou la prochaine assemblée annuelle des actionnaires, à condition que Ford reste en fonction. Après cette attribution, la participation directe bénéficiaire de Ford augmente à 250 609 actions.

Aucune action n’a été vendue, et aucun produit dérivé n’a été exercé ou cédé. Étant donné que cette attribution fait partie de la rémunération habituelle du conseil d’administration, l’impact financier pour Ford et la société est minime, mais le dépôt augmente légèrement l’alignement des intérêts des initiés. Le document ne contient aucune information opérationnelle, sur les résultats ou les prévisions.

8x8, Inc. (EGHT) � Form 4 Einreichung: Direktor Todd R. Ford erhielt am 25.07.2025 66.502 Restricted Stock Units (RSUs). Die Zuteilung hat einen Kaufpreis von 0 $ und wird zum früheren Zeitpunkt zwischen dem 25. Juli 2026 oder der nächsten jährlichen Hauptversammlung in Stammaktien übertragen und abgewickelt, vorausgesetzt, Ford bleibt im Dienst. Nach dieser Zuteilung erhöht sich Fords direkter wirtschaftlicher Besitz auf 250.609 Aktien.

Es wurden keine Aktien verkauft, und es wurden keine Derivate ausgeübt oder veräußert. Da die Zuteilung Teil der routinemäßigen Vergütung des Vorstands ist, ist die finanzielle Auswirkung für Ford und das Unternehmen minimal, jedoch erhöht die Einreichung geringfügig die Insider-Aktienausrichtung. Das Dokument enthält keine operativen, Gewinn- oder Prognoseinformationen.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14D-9

 

Solicitation/Recommendation Statement

Under Section 14(d)(4) of the Securities Exchange Act of 1934

 

 

 

Y-MABS THERAPEUTICS, INC.

(Name of Subject Company)

 

 

 

Y-MABS THERAPEUTICS, INC.

(Name of Persons Filing Statement)

 

 

 

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

 

984241109

(CUSIP Number of Class of Securities)

 

Michael Rossi

President and Chief Executive Officer

Y-mAbs Therapeutics, Inc.

202 Carnegie Center Drive

Suite 301

Princeton, New Jersey 08540

(646) 885-8505

(Name, address, and telephone number of person authorized to receive notices and communications

on behalf of the persons filing statement)

 

With a copy to:

Divakar Gupta

Sarah K. Sellers

Bill Sorabella

Bill Roegge

Cooley LLP

55 Hudson Yards

New York, New York 10001

(212) 479-6000

 

 

 

xCheck the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

 

 

 

 

 

This Schedule 14D-9 filing consists of certain communications relating to the proposed acquisition of Y-mAbs Therapeutics, Inc., a Delaware corporation (the “Company” or “Y-mAbs”), by Perseus BidCo US, Inc., a Delaware corporation (“Parent”), and Yosemite Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), pursuant to the terms and subject to the conditions of an Agreement and Plan of Merger, dated as of August 4, 2025 (the “Merger Agreement”), by and among the Company, Parent, Purchaser, and Stark International Lux, a Luxembourg private limited liability company (société à responsabilité limitée). Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, Purchaser will commence a tender offer (the “Tender Offer”) to acquire all of the outstanding shares of common stock of the Company, $0.0001 par value per share (the “Shares”), at an offer price of $8.60 per Share in cash, without interest, and subject to any applicable withholding taxes. If successful, the Tender Offer will be followed by a merger of Purchaser with and into the Company (the “Merger”) pursuant to Section 251(h) of the Delaware General Corporation Law, with the Company continuing as the surviving corporation in the Merger.

 

This Schedule 14D-9 filing consists of the following communications relating to the proposed Tender Offer and the Merger:

 

·Exhibit 99.1: Joint Press Release issued by Parent and the Company, dated August 5, 2025 (incorporated by reference to Exhibit 99.1 of the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission on August 5, 2025).

 

·Exhibit 99.2: Email from Michael Rossi, President and Chief Executive Officer of the Company, sent to employees, dated August 5, 2025.

 

·Exhibit 99.3: Investor/Analyst Letter, dated August 5, 2025.

 

·Exhibit 99.4: Patient and Patient Advocacy Organization Letter, dated August 5, 2025.

 

·Exhibit 99.5: Vendor/Supplier Letter, dated August 5, 2025.

 

·Exhibit 99.6: LinkedIn Post, dated August 5, 2025.

 

 

 

FAQ

How many shares did Director Todd R. Ford receive according to the EGHT Form 4?

66,502 RSUs were awarded on 07/25/2025.

When will the 8x8 RSUs granted to Todd R. Ford vest?

They vest on the earlier of July 25, 2026 or the next annual shareholder meeting, subject to continued service.

Did the Form 4 report any stock sales by the director?

No. The filing lists no dispositions or sales of common shares.

What is Todd R. Ford’s total beneficial ownership after the RSU grant?

Following the grant, he directly owns 250,609 EGHT shares.

Is there a purchase price associated with the RSU grant?

No. The RSUs were granted at $0 cost to the director.
Y-Mabs Therapeutics

NASDAQ:YMAB

YMAB Rankings

YMAB Latest News

YMAB Latest SEC Filings

YMAB Stock Data

385.92M
39.75M
12.01%
70.57%
5.49%
Biotechnology
Pharmaceutical Preparations
United States
PRINCETON